Evidence map›Paper›PMID 24748154›Full record

ArticlePloS one2014

The cost-effectiveness of wound-edge protection devices compared to standard care in reducing surgical site infection after laparotomy: an economic evaluation alongside the ROSSINI trial.

Adrian Gheorghe, Tracy E Roberts, Thomas D Pinkney, David C Bartlett, Dion Morton, Melanie Calvert, West Midlands Research Collaborative, ROSSINI Trial Investigators

Abstract readMulticenter Study
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Adrian GheorghePrimary Care Clinical Sciences, University of Birmingham, Birmingham, United Kingdom.
Tracy E RobertsHealth Economics Unit, University of Birmingham, Birmingham, United Kingdom.
Thomas D PinkneyAcademic Department of Surgery, University of Birmingham, Birmingham, United Kingdom; West Midlands Research Collaborative, Birmingham, United Kingdom.
David C BartlettWest Midlands Research Collaborative, Birmingham, United Kingdom.
Dion MortonAcademic Department of Surgery, University of Birmingham, Birmingham, United Kingdom; West Midlands Research Collaborative, Birmingham, United Kingdom.
Melanie CalvertPrimary Care Clinical Sciences, University of Birmingham, Birmingham, United Kingdom; West Midlands Research Collaborative, Birmingham, United Kingdom.
West Midlands Research Collaborative
ROSSINI Trial Investigators

Funding

Department of Health PB-PG-1208-18234
6 · The paper itself

Abstract

backgroundWound-edge protection devices (WEPDs) have been used in surgery for more than 40 years to reduce surgical site infection (SSI). No economic evaluation of WEPDs against any comparator has ever been conducted. The aim of the paper was to assess whether WEPDs are cost-effective in reducing SSI compared to standard care alone in the United Kingdom. METHODS AND

findingsAn economic evaluation was conducted alongside the ROSSINI trial. The study perspective was that of the UK National Health Service and the time horizon was 30 days post-operatively. The study was conducted in 21 UK hospitals. 760 patients undergoing laparotomy were randomised to either WEPD or standard care and 735 were included in the primary analysis. The main economic outcome was cost-effectiveness based on incremental cost (£) per quality adjusted life year (QALY) gained. Patients in the WEPD arm accessed health care worth £5,420 on average and gained 0.02131 QALYs, compared to £5,130 and 0.02133 QALYs gained in the standard care arm. The WEPD strategy was more costly and equally effective compared to standard care, but there was significant uncertainty around incremental costs and QALYs. The findings were robust to a range of sensitivity analyses.

conclusionsThere is no evidence to suggest that WEPDs can be considered a cost effective device to reduce SSI. Their continued use is a waste of limited health care resources.

Indexed as

Cost-Benefit AnalysisHealth Care CostsHumansLaparotomyQuality-Adjusted Life YearsRandomized Controlled Trials as TopicSurgical Wound InfectionUnited Kingdom

Identifiers

PMID24748154
PMCPMC3991705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.